col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


17 Results       Page 1

 [1] 
Knowledge E: Avicenna Journal of Medical Biotechnology
  original article Date Title Authors   All Authors
1 [GO] 2026―Feb―17 Expression, Purification, and Application of SARS-CoV-2 Nucleocapsid Protein for Serological Detection of IgG and IgM Antibodies Saeideh Zamani Koukhaloo, Farshid Moosavi, Bahareh Zamani, Niloofar Agharezaee, Parisa Yousefi, Mahboobeh Nazari, Jafar Mahmoudian
2 [GO] 2025―Jan―25 Isolation and Preliminary Characterization of a Novel scFv against SARS-CoV-2 : an Experimental and Computational Analysis Samaneh Jahandar-Lashaki, Safar Farajnia, Effat Alizadeh, Farzin Seirafi, Asghar Tanoumand, Mohammad Kazem Hosseini
3 [GO] 2023―Nov―27 One-step and Rapid Identification of SARS-CoV-2 using Real-Time Reverse Transcription Loop-Mediated Isothermal Amplification (RT-LAMP) Mohammad Shoushtari, Mehdi Zeinoddini, Javad Fathi, Hani Keshavarz Alikhani, Fatemeh Shiekhi
4 [GO] 2023―Feb―26 Interdisciplinary Collaboration between Bench and Bedside in the COVID-19 Pandemic Hossein Sanjari Moghaddam, Shahin Akhondzadeh
5 [GO] 2023―Feb―26 Human T2R38 Bitter Taste Receptor Expression and COVID-19: From Immunity to Prognosis Lakshmi Deepak Bethineedi, Hediyeh Baghsheikhi, Afsaneh Soltani, Zahedeh Mafi, Noosha Samieefar, Shaikh Sanjid Seraj, Mohammad Amin Khazeei Tabari
6 [GO] 2022―Sep―04 Antibodies Produced Toward Recombinant RBD and Nucleocapsid Neutralize SARS-COV-2 Amir Rezaei, Shahram Nazarian, Hossein Samiei Abianeh, Emad Kordbacheh, Zahra Alizadeh, Seyed Latif Mousavi Gargari
7 [GO] 2022―Jun―22 Investigation of Durability of SARS-CoV-2-specific IgG and IgM Antibodies in Recovered COVID-19 Patients: A Prospective Study Mohammad Zamani, Ahmad Ghasemi, Morteza Shamshirgaran, Sajjad Ahmadpour, Ahmad Hormati, Javad Khodadadi, et al. (+6)
8 [GO] 2022―Mar―13 Cellular Therapy: The Hope for Covid-19 Sima Nobari, Motahareh Rezvan, Fariba Dashtestani, Mahdieh Gangi, Hoda Keshmiri Neghab
9 [GO] 2022―Mar―13 Coronavirus Vaccination and Mortality in the Omicron Outbreak in Iran: Mortality Reduction due to Attenuated Pathogenicity and Booster Vaccine Doses Ahmad Shamabadi, Shahin Akhondzadeh
10 [GO] 2022―Jan―02 New Generation Vaccines for COVID-19 Based on Peptide, Viral Vector, Artificial Antigen Presenting Cell, DNA or mRNA Marzieh Rezaei, Mahboobeh Nazari
11 [GO] 2022―Jan―02 CRISPR-Cas System: A Promising Diagnostic Tool for Covid-19 Saeedeh Ebrahimi, Hashem Khanbabaei, Samaneh Abbasi, Mona Fani, Saber Soltani, Milad Zandi, Zahra Najafimemar
12 [GO] 2022―Jan―02 Protection against the Omicron and Subsequent Coronavirus Variants: Medical-grade Masking, Third Dose Vaccination, Updating Vaccines, and Pursuing Universal Vaccine Shahin Akhondzadeh, Ahmad Shamabadi
13 [GO] 2021―Sep―21 The Potential Anti-Inflammatory Effects of Zerumbone in COVID-19 Patients Razieh Dehghan, Mohammad Hasan Soheilifar, Farid Azizi Jalilian, Rezvan Najafi, Razieh Amini
14 [GO] 2021―Jun―13 The Novel Drug Discovery to Combat COVID-19 by Repressing Important Virus Proteins Involved in Pathogenesis Using Medicinal Herbal Compounds Samira Mahmoudi, Negar Balmeh, Niloofar Mohammadi, Tahereh Sadeghian-Rizi
15 [GO] 2021―Jun―13 Medical Biotechnology in the Service of Coronavirus Vaccine Discovery and Production Shahin Akhondzadeh, Ahmad Shamabadi
16 [GO] 2021―Feb―24 The Requisiteness for not Sacrificing Medical Biotechnology in the Coronavirus Era Shahin Akhondzadeh, Ahmad Shamabadi
17 [GO] 2020―Nov―11 Basic Science and Clinical Studies on Non-COVID-19 Topics, of Coronavirus Victims Shahin Akhondzadeh, Ahmad Shamabadi
 [1] 

17 Results       Page 1



[de][en]

Last change 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.042 sec